Plozasiran (ARO-APOC3) Decreases APOC3 and Triglycerides (TG) in Patients With Mixed Hyperlipidemia: MUIR Final Results
Plozasiran (ARO-APOC3) Decreases APOC3 and Triglycerides (TG) in Patients With Mixed Hyperlipidemia: MUIR Final Results
Overcoming Clinical Inertia in Hyperkalemia Management
Overcoming Clinical Inertia in Hyperkalemia Management
What Is the Acute and Post Acute Risk of VTE in Acute Medically Ill Patients?
What Is the Acute and Post Acute Risk of VTE in Acute Medically Ill Patients?
What Options Are Available Prophylactically for My Acute and Post-Acute Medically Ill Patients?
What Options Are Available Prophylactically for My Acute and Post-Acute Medically Ill Patients?
Case Time! V.T. Edwards: Management of Extended Thromboprophylaxis in the Medically Ill
Case Time! V.T. Edwards: Management of Extended Thromboprophylaxis in the Medically Ill
What Do the Guidelines Suggest for Prophylaxis, and How Do We Implement?
What Do the Guidelines Suggest for Prophylaxis, and How Do We Implement?
Right from the Onset: DVT Diagnosis, Management
Right from the Onset: DVT Diagnosis, Management
Right from the Onset: PE Diagnosis, Management
Right from the Onset: PE Diagnosis, Management
Case Time! VTE Prophylaxis Post Hip Replacement
Case Time! VTE Prophylaxis Post Hip Replacement
Putting It All Together: Coordinating the Multidisciplinary Care Plan for the Patient With VTE
Putting It All Together: Coordinating the Multidisciplinary Care Plan for the Patient With VTE
Risk Assessment: Who’s Most Susceptible for a Secondary VTE Event?
Risk Assessment: Who’s Most Susceptible for a Secondary VTE Event?
VTE Prophylaxis in Patients at Risk for a Secondary VTE Event - Options?
VTE Prophylaxis in Patients at Risk for a Secondary VTE Event - Options?
Mrs. V.T. Elizabeth: A Case Study on the Secondary Prevention of VTE
Mrs. V.T. Elizabeth: A Case Study on the Secondary Prevention of VTE
How Do We Effectively Integrate the Latest VTE Treatment and Secondary Prevention Guidelines Into Clinical Practice?
How Do We Effectively Integrate the Latest VTE Treatment and Secondary Prevention Guidelines Into Clinical Practice?